In our study, there was a significant reduction in the incidence of hypertension among perimenopausal women receiving HT, which we considered to be related to hormone therapy improving the biological effects of nitric oxide (NO) and reducing the effects of angiotensin II, thereby causing vasodilation and leading to a decrease in blood pressure [29]. Here, AGT is linked to hypertensive disorder.